Dr Atul Gawande will lead the joint healthcare venture between Amazon, J.P. Morgan and Berkshire Hathaway, the three companies announced Wednesday.
Berkshire Hathaway CEO Warren Buffett, J.P. Morgan CEO Jamie Dimon and Amazon CEO Jeff Bezos announced a partnership in January to tackle rising health-care costs.
They will form a new company for the venture, which will be headquartered in Boston, a hub for biotechnology and medical research. It will be ‘free from profit-making incentives and constraints.’
Gawande will start July 09. Dr Atul Gawande is surgeon at Brigham and Women’s Hospital and a professor at both Harvard’s medical school and its school of public health.
He is founding executive director of Ariadne Labs, a health systems innovation center. He’s also written numerous books, including “Being Mortal” and “The Checklist Manifesto.”
Gawande will transition to chairman of Ariadne Labs from executive director, the organization said in a press release. He will not give up his positions at Harvard or Brigham and Women’s Hospital and will keep writing, including for The New Yorker.
“I’m thrilled to be named CEO of this healthcare initiative,” Gawande said in a statement. “I have devoted my public health career to building scalable solutions for better healthcare delivery that are saving lives, reducing suffering, and eliminating wasteful spending both in the US and across the world.